News and Events

The pharmaceutical world is constantly evolving so it is paramount to stay up-to-date. Keep abreast of all Quinta's announcements, insights and activities, as well as wider industry news right here.

January 26, 2023

Pharmaceutical Offshore Outsourcing in the USA: Opportunities & Misconceptions

Dr. Jeffrey Kiel, founder and CEO of Kiel Laboratories, talks about offshore outsourcing in the USA and working with Quinta-Analytica.

January 5, 2023

From Houston to Munich - Innovation & Compounding

Pharma innovators often outsource demanding projects to specialist CROs. Gus Bassani of US-based PCCA and Markus Dachtler of Conscio's German subsidiary Gen-Plus, share lessons from their collaboration.

December 7, 2022

Quinta's Another Two Successful FDA Inspections

We at Quinta-Analytica are proud to announce the successful completion of not 1 but 2 FDA inspections at our Prague and Brno sites. Thanks for your trust and support!

November 24, 2022

The Secret Behind 25 Years of Excellence

Quinta-Analytica's 25th Anniversary give us the chance to look back at our successful trajectory of proactiveness, technical expertise and improvement in the company of Dr Miroslav Ryska, mass spectrometry expert and founder of Quinta.

November 16, 2022

Clinical Tips: Intra- and Inter-subject Variability

Interested in clinical study design? Today's Clinical Tips series focuses on intra- and inter-subject variability, crucial concepts for the correct calculation of sample size.

October 30, 2022

CPHI Frankfurt 2022: See you there!

Quinta-Analytica is attending CPHI 2022 in Frankfurt

October 13, 2022

New Stability Models for Faster & Better Shelf Life Estimations

Are you a pharma company in need of stability testing but have just too many candidates to screen with conventional ICH assays? We at Quinta-Analytica can offer you accurate stability data 3 times faster than usual! Find out more below.

September 8, 2022

ADC characterisation: When small & large molecules collide

Quinta-Analytica is among the few CROs offering GCP/GLP/GMP services for biologics. We and our valued biotech client SOTIO wish to share our experience with antibody-drug conjugates, the toughest biologics.

August 30, 2022

Clinical Tips: Linear & non-linear PK

QUINTA is well-known for its state-of-the-art equipment and facilities used to perform clinical trials and bioanalytical services under GCP/GLP; but today our experts wish to talk about pharmacokinetics and statistical evaluations, an important part of their day to day work which doesn't always get the attention it deserves. Click and keep reading!

August 11, 2022

Gen-Plus + Conscio Partnership

Today we proudly announce that Gen-Plus GmbH & Co. KG, a Munich-based pharma R&D and manufacturing expert, has become a new member of the Conscio Group.

July 28, 2022

Quinta-Analytica + Olga Havel Foundation - Helping to Help Others

We are proud to announce that Quinta-Analytica has donated 100,000 CZK to the Olga Havel Foundation for the support of six families with members in need of neurorehabilitation.

June 22, 2022

Nitrosamine Analogues: Stepping up to a new Challenge

Have you heard about Nitrosamine Analogues? Did you know even if a tested API is free of nitrosamine analogues, its related drug product may still contain high amounts of these new impurities? Keep reading to learn more!

May 26, 2022

Clinical Tips: Bioequivalences with urinary data

Volunteers participating in trials at our clinical unit are sometimes surprised to discover that samples collected during the studies are not always blood but can also involve other biological fluids such as urine. Keep reading to learn more about our clinical R&D activities.

May 12, 2022

Liquid Chromatography Apparatus Just Got Even Better.‍

The introduction of Ultra-High Performance Liquid Chromatography was a significant milestone in the evolution of LC, and is certainly a very powerful tool for today’s chromatographer

May 4, 2022

What are Endogenous Substances? And how can they be identified?

The bioequivalence of generic versions of certain reference drugs can often be complicated by the presence of endogenous levels of compounds, so how can you identify them?

April 21, 2022

Problem Packaging. The next safety concern?‍

Prior to the release of a #pharmaceutical, it has always been necessary to determine the impurity profile of the final product, however nowadays the impurities from the components used during manufacture and storage must be also considered.

April 7, 2022

Are you Ukrainian and looking for work in the Czech Republic?

Ви українець та шукаєте роботу в Чехії? | Are you Ukrainian and looking for work in the Czech Republic? | Jste z Ukrajiny a hledáte práci v České republice?

March 24, 2022

Sampling Time in Pharmacokinetics. Getting it right, matters.

The design of pharmacokinetic sampling times plays a critical role in the reliability of bioequivalence evaluation, as does ensuring that enough samples are collected.

March 10, 2022

In the world of science and pharmaceuticals, details matter.

Cancer biologists at a world-renowned university have developed a new piece of technology that will help researchers see cells in more precise detail

February 24, 2022

Current Antibacterial Drug Development

Deaths caused by infectious diseases have fallen by 70% since antibiotics were introduced on a large scale in the 1940s, yet we’ve seen a significant decrease in the number of new antibiotics reaching the market and this could be an issue.

February 10, 2022

Advancement For Animal Medicine

Finally, for the first time, information about all veterinary medicines authorized in the EU and European Economic Area (EEA) countries will be available on a central website.

January 27, 2022

Immense Tasks. Incredible Teams. Ingenious Instruments.

Flagged as the next generation of ultra-performance instrumentation, the high resolution of the quaternary LC System offers a significant improvement when compared to older models.

January 20, 2022

Accelerating Clinical Trials in the EU

The European Commission, HMA, and EMA have launched an initiative to transform how clinical trials are run across the union.

January 13, 2022

Validating BioAnalytical Methods

The measurement of drug concentrations in biological matrices is an important aspect of medicinal product development.

January 6, 2022

Pharmacokinetics: Complex Yet Fascinating

This key branch of pharmacology is dedicated to determining the fate of substances administered to a living organism, such as pharmaceutical drugs, pesticides, and food additives.

December 20, 2021

Happy Holidays and a Joyous New Year

As the Holiday Season is upon us, we find ourselves reflecting on the past year, and what a rollercoaster it has been!

December 16, 2021

Widespread use of real-world evidence in EU medicines regulation

Real-world data and real-world evidence are already used in the regulation of some medicines across the EU, but the vision is that by 2025 the use of RWE will have been fully enabled.

December 9, 2021

Thank You to our Clinical Team

When we look back at the people that kept the world turning during these difficult times, we pay our thanks to those who continued to enable drug development and safely help bring drugs to market in the quickest possible way.

December 2, 2021

New investment from BBA CapitalPartners

QUINTA-ANALYTICA are very happy to announce new investment from renowned family equity firm BBA CapitalPartners.

November 25, 2021

Giving Back, One Tree at a Time

With the world waking up to the effects of climate change, QUINTA-ANALYTICA have taken their own first small step this week in giving back, one tree at a time.

November 18, 2021

The Rapid Expansion of AI in Pharma

With Artificial Intelligence penetrating the pharma world at a rapid pace, three regulators have joined forces with the aim of fostering Good Machine Learning Practice (GMLP).

November 10, 2021

Good Morning CPhI 2021, Day Two!

Following a thrilling first day in milano at the fieramilano exhibition space, CPhI gets underway for day two and the QUINTA-ANALYTICA team are fired up and raring to go.

November 9, 2021

Welcome to CPhI 2021!

As CPhI Worldwide gets underway, the QUINTA-ANALYTICA team are all set up here in milan and ready to welcome you.

November 4, 2021

Meet Us in Milan!

Billed as the biggest pharma event of the year, CPhI 2021 is a prime opportunity to make new connections and meet the QUINTA-ANALYTICA team.

October 28, 2021

Testing of Highly Variable Drugs

HVD are drugs whose within-subject variance is larger than preset regulatory bioequivalence limits. How do we properly measure and test these types of drugs?

October 21, 2021

Exploring Narrow Therapeutic Index Drugs

Narrow therapeutic index (NTI) drugs are defined as those drugs where small differences in dose, or concentration in the blood, may lead to serious therapeutic failures or adverse drug reactions.

October 14, 2021

Food Effect Studies

We all love to eat, but many people are unaware of the correlation between food and medicine effectiveness.

October 6, 2021

CPhI Worldwide 2021 Milan

As many of us struggle to believe it’s October already, the realization of that calendar milestone also means we’re just one month away from the biggest pharma event of the year, CPhI Worldwide.

September 30, 2021

Brno is brimming with best-in-class equipment

It may be the Czech Republics’ second-largest city, but there’s nothing second about the knowledge and long-term experience of dissolution testing brought to the city by its new pharma resident, QUINTA-ANALYTICA.

September 23, 2021

Why Do We Test On Healthy Volunteers?

Bioequivalence and bioavailability studies should be conducted preferentially from a healthy volunteer population unless the drug carries safety concerns that make this unethical.

September 15, 2021

Quinta Summer Fun

In keeping with the annual tradition of celebrating the wind down from summer, the teams at QUINTA-ANALYTICA certainly let their hair down in style last Friday.

September 9, 2021

Announcing Conscio Pharmaceuticals

Quinta are enormously proud to announce the opening of their new, USA-based affiliate company, Conscio Pharmaceuticals Inc.

September 2, 2021

Understanding drug distribution in the body

Administration of medication requires a thorough understanding of how and when it moves through the body, possible side effects or reactions, and the correct way to deliver it.

August 26, 2021

Keeping Your Pets Safe

It’s not always easy to manage the array of dietary requirements, veterinary needs, and overall health of your furry, fluffy, or indeed scaly companions.

August 18, 2021

Is mRNA the future of modern science?

As the prevalence of mRNA vaccines starts to take a solid foothold and their development rapidly into other medicinal areas hits new heights, finding the right pharma services company has become ever more a challenge.

August 12, 2021

Case Study: Analytical Method Validation

Whatever size your firm, it's essential to deliver on client expectations.

August 5, 2021

Is A Pilot Study Useful?

Before taking the plunge and carrying out a full-scale bioequivalence trial, it is typically desirable to dip your toe in the water, and often makes a lot of business sense, to first conduct a pilot trial.

July 28, 2021

DeepMind AI Research Openly Available

The information that has been unlocked is vast, and indeed is being hailed as one of the most important datasets since the mapping of the Human Genome.

July 21, 2021

Clinical Trial Information System (CTIS)

Soon to become the single entry point for submitting clinical trial information in the EU, we present the Clinical Trial Information System (CTIS).

July 15, 2021

Role of SMEs in Pharma

Are small and medium enterprises (SME’s) really a major driver of innovation in the pharmaceutical industry?

July 7, 2021

CPhI Nitrosamines Impurities Forum 2021

It's clear to see the continued dominance of the Nitrosamines topic, and the impact the stringent rules and regulations are having on the industry.

July 1, 2021

Assessment of Bioequivalence

Nothing short of complex, and requiring highly intricate detail to conduct, the assessment of bioequivalence is a critical component in getting any new drugs to market.

June 28, 2021

Let’s Talk Nitrosamines

This week sees the pharma industry get together virtually once more as the CPhI Conferences Nitrosamine Impurities Forum 2021 gets underway.

June 23, 2021

Conducting Parallel Studies

Before a new medicine or biologic can be marketed, its sponsor must show, through adequate and well-controlled clinical experiments, that it is effective.

June 17, 2021

Stability Chambers

As everyone in the pharma world knows, stability testing is one of the most crucial steps in the development of new drug products.

June 10, 2021

The Role of Quality Assurance

Across the pharma world, the alignment to guidelines and rules set out by the regulatory authorities must be not only met but exceeded in order to deliver success.

June 3, 2021

Summer and Team Celebration

This week we celebrated our teams, getting back to normal, and the arrival of summer.

May 27, 2021

Artificial Intelligence and Pharma

World-leading companies such as QUINTA-ANALYTICA are embracing new technologies critical to revolutionizing research, attracting patients for trials, and reducing the speed of delivering results.

May 24, 2021

EU Funding for Quinta's Brno Lab

Quinta has received EU funding toward the construction of it's new research and development laboratory in Brno, Czech Republic.

May 19, 2021

Leveraging Crossover Trials

Crossover trials are clinical experiments in which participants are randomly assigned to a sequence of treatments wherein each participant serves as their own control in estimating effects.

May 13, 2021

The Importance of Human Relations

As an employer of hundreds of professionals, QUINTA-ANALYTICA takes staff engagement, motivation, and culture incredibly seriously.

May 6, 2021

Our New Electron Capture Detector

The team are pleased to announce delivery of our latest innovative piece of technology, allowing us to offer even greater selectivity and sensitivity to our clients and partners.

April 28, 2021

Quinta-Analytica awarded EcoVadis medal

EcoVadis is the world’s most trusted provider of business sustainability ratings, and their sustainability scorecard ranked Quinta amongst the top companies assessed.

April 22, 2021

Quinta-Analytica Passes Inspection

Quinta-Analytica's facilities in our HQ in Prague and also at our newest lab in Brno passes the latest GMP inspection by the Czech State Institute for Drug Control, SUKL.

April 15, 2021

Step Inside Analytical R&D

If you’re developing volatile compounds, struggling with in-vitro testing, or looking for someone who has Franz diffusion cell expertise for your permeation studies, look no further.

April 8, 2021

The Value of Generic Medicine

A generic drug contains the same chemical substance as a drug that was originally branded and protected by patents (now expired).

April 1, 2021

Quinta-Analytica and Greene Street Pharmaceuticals

Although an ocean may divide them, when it comes to choosing the right pharma services company, distance knows no bounds.

March 25, 2021

Step Inside Clinical Testing

Offering a full range of clinical pharmacology solutions, bioavailability, interaction, bioequivalence, and much more, our purpose-built clinic allows for a huge range of trials.

March 17, 2021

Repositioning of Existing Drugs

The repositioning of existing drugs could be one of the keys to quickly seek effective drugs to reduce mortality and morbidity.

March 10, 2021

Step Inside Biopharmaceutical Analyses

An essential part of QUINTA-ANALYTICA’s service portfolio, its BioPharma team offers comprehensive support.

March 4, 2021

Fresh Website Update for 2021

The world moves forward, and so do we. Introducing our new look website.

February 25, 2021

Step Inside QC Project Coordination

Quality Control project management is an independent and essential function within the analytical operations department.

February 18, 2021

Bioequivalence in Pharmacokinetics

Offering extensive experience in the field of bioequivalence studies from project design and documentation, through clinical and bioanalytical work complete with full statistical clinical reports.

February 11, 2021

Step Inside Pharmaceutical Analyses

Working both with methods provided by customers and those developed by our Analytical R&D teams, we offer a very flexible approach to meet your needs and be your true pharma partner.

February 4, 2021

Step Inside Bioanalytical Department

Offering a comprehensive range of services including testing of the application form of drugs to guarantee compliance with exact specifications, our Bioanalytical laboratory is here to support all analytical aspects of your clinical and pre-clinical tests.

January 27, 2021

High Performance Viscometer

Viscosity is a principal parameter when any flow measurements of fluids, such as liquids, semi-solids, gases, and even solids are made.

January 19, 2021

Fighting Antimicrobial Resistance

The world is fast running out of effective antibiotics as bacteria evolve to develop resistance to our taken-for-granted treatments.

January 12, 2021

Monitoring Covid-19 Drugs

This presentation by the European Medicines Agency on Covid-19 drug testing monitoring.

January 7, 2021

Step Inside API Solutions

Our API Solutions truly remove complexity and bring true value to your developmental process.

December 28, 2020

Your world-class partner for preclinical studies

Offering a comprehensive end-to-end service in collaboration with a strategic partner, QUINTA-ANALYTICA can offer everything from preclinical development to toxicological (TK) studies.

December 21, 2020

Wishing you a healthy, prosperous and exciting 2021!

Wishing our clients, colleagues, and friends all the very best for a healthy, prosperous, and exciting 2021!

December 17, 2020

How do YOU test the purity of your products?

Offering incredible accuracy and lightning-fast results, there is no better way to verify the identity of precursor materials used in the preparation of your drugdevelopment.

December 9, 2020

Introducing our new Head of Quality Assurance

We are exceptionally proud to welcome to our team, starting January, our new Head of Quality Assurance, Dr. Miroslav Janousek!

December 2, 2020

Introducing our new Head of Clinical Department

We are excited and very proud to welcome Dr. Ondrej Palan to the Quinta team!

November 26, 2020

Staying Safe This Holiday Season

Stay safe and celebrate this holiday season in good health!

November 19, 2020

Prepare to package

Regardless of the study phase, magnitude of the trial, dosage forms, or trial design, getting your packaging and labeling right is critical.

November 12, 2020

Electrochemiluminescence Detection System

Electrochemiluminescence is a highly successful detection system that achieves clinical quality data in a variety of sample types.

November 5, 2020

IMI Stakeholder Forum 2020

The free-of-charge event strives to get the widest audience possible from health and medicines R&D together.

October 29, 2020

Brexit and the Pharma Industry

With Brexit looming and the UK PM Boris Johnson saying last week that we must prepare for 'no deal', the pharma industry is on tenterhooks.

October 23, 2020

Unique Medicines for Unique People

The pharmaceutical industry is seeing a shift toward personalized medicines, and it’s evolving to deliver this via some exciting new tools.

October 16, 2020

The EMA Goes DIgital

Starting October 19th developers of human or veterinary medicines are instructed to use the EMA's new platform to request scientific advice.

October 9, 2020

Transparency for COVID-19 Vaccines

It should be a given fact for an industry so important to the world as pharmaceutical, but it’s still reassuring to see it announced publicly.

September 29, 2020

How we indentify unknown impurities

With some of the best chemists in the industry using state of the art science and lab techniques, it now really is possible to identify the unidentified!

September 22, 2020

FDA Updates for conducting Clinical Trials during the #COVID-19 pandemic

Here’s what you need to know from the FDA’s updated guidance for clinical trials during the pandemic.

September 17, 2020

Royal Society of Chemistry Releases 160 years of research

The Royal Society of Chemistry has announced that its full collection of research journals are now available.

September 9, 2020

Suspension of Generics

If your drug has been suspended, get in touch to see how we can help.

September 2, 2020

COVID-19 and the Pharma Industry

Working with key research projects Quinta are proud to be doing their part in the collective effort to rid the world of the most impactful issue ever seen.

August 27, 2020

French Tax Credit System

Quinta have been granted approval into the French Tax Credit system.

August 17, 2020

Let’s (virtually) connect!

We’ll be attending the “Nitrosamines Impurities Forum (Americas)” next week. Will you join us?

August 11, 2020

Nitrosamine Deadline Extended AGAIN!

The European Medicines Agency just announced yet another extension for the testing of Nitrosamines contamination.